CDEK by Data4ThePeople

Sign in Sign up

← All drugs Report issue

H22xKi-4

mAbexperimentalBi-specific

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

High affinity immunoglobulin gamma Fc receptor IANTAGONIST
FCGR1A antagonist
- High affinity immunoglobulin gamma Fc receptor I (FCGR1A) ↗
Tumor necrosis factor receptor superfamily member 8ANTAGONIST
CD30
- Tumor necrosis factor receptor superfamily member 8 (TNFRSF8) ↗

Chemistry & pharmacology

Multi-specific: Yes (Bi-specific)

Oral

No

Parenteral

No

Topical

No